查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1868411

冠状动脉绕道手术移植器械市场：按产品类型、移植类型、手术类型、最终用户划分 - 全球预测 2025-2032

Coronary Artery Bypass Graft Devices Market by Product Type, Graft Type, Procedure Type, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，冠状动脉绕道手术手术装置市场将成长至 249.2 亿美元，复合年增长率为 6.65%。

关键市场统计数据
基准年 2024 148.8亿美元
预计年份：2025年 158.6亿美元
预测年份 2032 249.2亿美元
复合年增长率 (%) 6.65%

在冠状动脉绕道手术手术器械领域，提供清晰权威的指导，阐明临床重点、技术发展和相关人员的期望。

冠状动脉绕道手术手术器械领域在心血管外科中占据核心地位，它既要平衡既有的外科手术实践，又要兼顾持续的技术发展。临床医生继续依赖成熟的技术，而器械製造商和医疗系统则致力于推进渐进式和颠覆性创新，以提高手术安全性、减少手术全期手术期併发症并缩短恢復时间。在此背景下，相关人员如今将临床疗效、易用性和供应链韧性视为影响器材应用决策的同等重要因素。

临床偏好的改变，以及由此对技术整合和供应链韧性的影响，正在重塑 CABG 手术的设备选择、实施和筹资策略。

随着临床、技术和操作因素的融合，冠状动脉绕道手术手术器械领域正经历变革性的转变。微创手术和非体外循环手术技术的兴起，推动了对专用吻合和稳定器械的需求，这些器械能够在狭小的手术空间内实现精准操作。同时，体外循环系统的改进也更加重视便携性、生物相容性和降低发炎反应。这些趋势正在重新定义手术室和心臟中心的采购标准，促使医疗机构根据预期的临床效益和工作流程效率来评估资本投入。

2025年美国关税的累积影响评估：对冠状动脉绕道手术手术（CABG）器械供应链选择、製造本地化和采购惯例的影响

美国2025年实施的关税政策对冠状动脉绕道手术手术器械价值链产生了累积影响，迫使製造商和采购商重新评估其采购和製造地。关税上调推高了进口器械组件和成品的到岸成本，进而影响了医院和门诊手术中心的采购决策。为因应此变化，多家国际供应商调整了商业策略以保持竞争力，包括扩大区域生产能力、重新谈判供应商合约以及加速对本地组装业务的投资。

多维度细分洞察，阐释产品类型、移植选择、手术类型和终端用户趋势如何影响医疗设备的开发、应用和采购。

冠状动脉绕道手术手术器械市场的细分揭示了创新、临床偏好和采购重点之间的交集。基于产品类型的市场格局包括吻合器、心肺体外迴圈系统、钳夹和闭塞器以及稳定器。吻合器进一步细分为压迫式吻合环和缝合器；心肺体外迴圈系统细分为可携式系统和标准体外循环机；钳夹和闭塞器细分为主动脉钳和血管闭塞器；稳定器为机械稳定器和吸力稳定器。这种产品层面的细分使相关人员能够将手术要求与器械功能相匹配，并评估一次性器械的便利性和可重复使用设备之间的权衡。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 越来越多地采用非体外迴圈冠状动脉绕道手术手术装置，以减轻患者负担并缩短恢復时间
  • 机器人辅助冠状动脉绕道手术手术系统的快速技术进步提高了手术精度。
  • 对能够克服传统大隐静脉移植限制的生物工程和组织工程移植物的需求日益增长
  • 透过整合先进的影像技术和术中血流测量设备，加强对旁路移植血管通畅性的监测。
  • 扩大微创内视镜和胸腔镜手术的应用范围，以缩短冠状动脉绕道手术（CABG）的住院时间和併发症率。
  • 透过医疗设备製造商和研究机构的合作，开发具有更高生物相容性的下一代合成移植材料
  • 人们对用于冠状动脉绕道术(CABG) 术前规划的患者特异性3D 列印手术导板和患者解剖模型越来越感兴趣。
  • 采用混合冠状动脉重组策略，将经皮治疗与微创搭桥手术结合，以优化复杂病例的治疗效果。
  • 在亚洲和拉丁美洲等新兴医疗保健市场，监管核准和报销政策的增加有利于先进的冠状动脉绕道术（CABG）器械的发展。
  • 利用人工智慧和巨量资料分析预测冠状动脉绕道手术患者的移植物通畅率，并实现个人化术后护理

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章冠状动脉绕道手术移植器械市场（按产品类型划分）

  • 吻合装置
    • 压迫吻合环
    • 订书机
  • 心肺体外迴圈系统
    • 可携式系统
    • 标准心肺体外迴圈机
  • 夹钳和封堵器
    • 主动脉钳夹
    • 血管闭合装置
  • 稳定器
    • 机械稳定器
    • 吸盘式稳定器

第九章 依移植类型冠状动脉绕道手术移植器械市场

  • 动脉移植
    • 乳内动脉
    • 桡动脉
  • 静脉移植
    • 大隐静脉

第十章 依手术方式冠状动脉绕道手术手术器械市场

  • 非泵送
  • 泵浦上

第十一章冠状动脉绕道手术移植器械市场（按最终用户划分）

  • 门诊手术中心
  • 医院

第十二章冠状动脉绕道手术移植器械市场（按地区划分）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章冠状动脉绕道手术移植器械市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 各国冠状动脉绕道手术手术装置市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Medtronic plc
    • Abbott Laboratories
    • Johnson & Johnson
    • Terumo Corporation
    • B. Braun Melsungen AG
    • Getinge AB
    • LivaNova PLC
    • CryoLife, Inc.
    • Teleflex Incorporated
    • AtriCure, Inc.
Product Code: MRR-6A132FD325F8

The Coronary Artery Bypass Graft Devices Market is projected to grow by USD 24.92 billion at a CAGR of 6.65% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 14.88 billion
Estimated Year [2025] USD 15.86 billion
Forecast Year [2032] USD 24.92 billion
CAGR (%) 6.65%

A clear and authoritative orientation to the coronary artery bypass graft device landscape that frames clinical priorities technological evolution and stakeholder expectations

The coronary artery bypass graft device domain occupies a central role in cardiovascular surgery, balancing established surgical practice with persistent technological evolution. Clinicians continue to rely on proven techniques while device manufacturers and healthcare systems pursue incremental and disruptive innovations that improve procedural safety, reduce perioperative morbidity, and shorten recovery timelines. Against this backdrop, stakeholders now weigh clinical outcomes, ease of use, and supply chain resilience as equally important determinants of adoption decisions.

Recent advances in materials science, device ergonomics, and perfusion technology have reshaped clinical workflows, enabling teams to refine operative strategies and expand the treatment population. At the same time, regulatory scrutiny and payer requirements are prompting manufacturers to demonstrate robust evidence of procedural benefit and device reliability. As a result, the landscape is increasingly defined by the interplay of surgical technique preference, device capability, and institutional capacity to integrate new technologies into complex care pathways.

How clinical preference shifts technological integration and supply chain resilience are jointly reshaping device selection adoption and procurement strategies in CABG care

The landscape for coronary artery bypass graft devices is undergoing transformational shifts driven by converging clinical, technological, and operational forces. Minimally invasive approaches and off-pump techniques have stimulated demand for specialized anastomosis devices and stabilizers designed to facilitate precision in constrained operative fields, while improvements in cardiopulmonary bypass systems emphasize portability, biocompatibility, and reduced inflammatory response. These trends have redefined procurement criteria for surgical suites and cardiac centers, prompting institutions to evaluate capital acquisition against anticipated clinical gains and workflow efficiency.

Parallel to clinical innovation, digital augmentation and the rise of integrated operating room platforms are changing the expectations for device interoperability. Surgeons and perfusionists increasingly expect devices that support data capture, intraoperative visualization, and post-operative performance analytics. Consequently, manufacturers are investing in modular designs and connectivity features that enable better integration with hospital information systems and procedural analytics. Supply chain strategies have also adapted, with a renewed emphasis on dual-sourcing, localized manufacturing, and inventory optimization to mitigate disruptions and meet heightened regulatory compliance demands.

Assessment of the cumulative effects of the 2025 United States tariff measures on supply chain choices manufacturing localization and procurement practices for CABG devices

United States tariff policy introduced in 2025 has had a cumulative impact on coronary artery bypass graft device value chains, compelling manufacturers and purchasers to reassess sourcing and manufacturing footprints. Tariff escalation increased landed costs for imported device components and finished goods, which in turn affected procurement decisions across hospitals and ambulatory surgical centers. In response, several international suppliers recalibrated their commercial strategies by expanding regional manufacturing capacity, renegotiating supplier agreements, and accelerating investments in local assembly operations to preserve competitiveness.

Clinicians and hospital purchasing teams experienced operational implications as procurement windows tightened and lead-time variability increased. Some institutions prioritized devices with established local supply or those produced by manufacturers with nearshore facilities to ensure continuity of care. At a policy and industry level, there was a marked increase in dialogue between trade policymakers, medical device associations, and hospital consortia to explore tariff exemptions for clinical-critical components and to identify opportunities for incentivizing domestic production. The net effect has been a more intentional approach to supply chain risk management and a renewed focus on bilateral supplier relationships that balance cost, reliability, and regulatory compliance.

Multidimensional segmentation insights explaining how product type graft selection procedural modality and end user dynamics influence device development adoption and procurement

Segmentation of the coronary artery bypass graft device domain illuminates where innovation, clinical preference, and procurement focus converge. Based on Product Type, the landscape comprises Anastomosis Devices, Cardiopulmonary Bypass Systems, Clamps & Occluders, and Stabilizers, with Anastomosis Devices further distinguished by Compression Anastomosis Rings and Stapling Devices, Cardiopulmonary Bypass Systems subdivided into Portable Systems and Standard Heart-Lung Machines, Clamps & Occluders categorized into Aortic Clamps and Vascular Occluders, and Stabilizers segmented into Mechanical Stabilizers and Suction Stabilizers. This product-level granularity helps stakeholders match procedural requirements to device capabilities and assess trade-offs between single-use convenience and reusable capital equipment.

Based on Graft Type, the clinical and procurement conversation differentiates Arterial Grafts and Venous Grafts, with Arterial Grafts further examined through Internal Mammary Artery and Radial Artery use cases, and Venous Grafts represented primarily by the Saphenous Vein. These graft distinctions influence surgeon technique, device selection for anastomosis delivery, and perioperative management protocols. Based on Procedure Type, the dichotomy between Off-Pump and On-Pump approaches continues to shape the adoption curve for certain devices, as off-pump cases place a premium on stabilizers and anastomosis solutions that perform reliably in a beating-heart environment, while on-pump procedures create different perfusion and clamp requirements.

Based on End User, device adoption and purchasing dynamics diverge between Ambulatory Surgical Centers and Hospitals, with ambulatory settings often prioritizing devices that enable rapid turnover and simplified workflows, whereas hospitals weigh long-term capital utilization, support contracts, and cross-procedural versatility. Together, these segmentation lenses provide a multidimensional view that informs product development priorities, clinical training initiatives, and procurement negotiations.

Regional dynamics and differentiated adoption profiles across the Americas Europe Middle East Africa and Asia-Pacific shaping clinical practice and supplier strategy

Regional dynamics exert a strong influence on clinical practice patterns, regulatory pathways, and procurement strategies for coronary artery bypass graft devices. In the Americas, clinical centers often balance highly developed tertiary care networks with diverse procurement models that range from centralized group purchasing organizations to hospital-level sourcing, creating a competitive environment for suppliers that can provide clinical evidence and service support. In Europe, Middle East & Africa, regulatory harmonization efforts, varying reimbursement environments, and heterogeneous hospital capabilities shape differentiated adoption profiles where some high-volume centers lead clinical innovation while others prioritize cost containment and device reliability.

Across the Asia-Pacific region, rapid expansion of cardiovascular care capacity, investment in tertiary centers, and government-led manufacturing initiatives have reshaped demand patterns. Local manufacturing incentives, coupled with active clinical training programs, have accelerated adoption of both standard and portable cardiopulmonary systems. Transitional economies within the region balance access constraints with growing procedural volumes, which encourages suppliers to tailor commercial models that include managed services, training partnerships, and flexible financing. These regional distinctions highlight the necessity for manufacturers to adopt segmented go-to-market strategies that align clinical engagement, after-sales service, and regulatory expertise with local health system priorities.

Competitive and collaborative company dynamics highlighting how incumbents specialized innovators and new entrants drive product evolution clinical adoption and commercial differentiation

Competitive dynamics in the coronary artery bypass graft device arena reflect a mix of established multinational medical device corporations, specialized surgical device innovators, and agile startups introducing focused innovations. Established device manufacturers leverage extensive clinical relationships, integrated service networks, and regulatory experience to maintain installed base advantages, while specialized firms compete on innovation in staple anastomosis technologies, minimally invasive stabilizers, and next-generation perfusion systems. This competitive balance drives a continuous cycle of product refinement, clinical evidence generation, and targeted training programs to secure preference within surgical teams.

Strategic activity includes partnerships between device firms and hospital systems to pilot new technologies and collect real-world performance data, licensing agreements that broaden device availability, and vertical integration moves that bring consumables and capital equipment under common service contracts. Competitive pressure also incentivizes investment in value-added services such as remote device monitoring, clinician training modules, and consumable management. For new entrants, differentiation often hinges on demonstrating procedural efficiency, ease of adoption, and robust post-market clinical data that resonates with both surgeons and institutional procurement committees.

Practical high-impact strategies for manufacturers and health systems to accelerate clinical adoption enhance device resilience and strengthen value-driven procurement outcomes

Industry leaders should prioritize a set of actionable strategies to align product development, clinical adoption, and supply chain resilience. First, invest in evidence generation that couples procedural outcomes with device-specific advantages, leveraging multicenter clinical collaborations and registry-based studies to create compelling clinical narratives. Second, design products with modularity and interoperability in mind to meet the growing demand for integrated operating room ecosystems and data-driven performance monitoring. These product attributes reduce friction at the point of care and facilitate institutional procurement decisions.

Third, adopt supply chain diversification strategies that balance cost optimization with redundancy, including regional assembly, multiple qualified component suppliers, and scalable inventory management to address tariff-related uncertainties and logistical disruptions. Fourth, engage early and consistently with clinical champions and perfusion teams to build training curricula and onboarding programs that shorten the learning curve for new devices. Finally, explore commercial models that go beyond transactional sales-service contracts, outcome-based pricing pilots, and managed device programs can align incentives with health systems and create longer-term value. Together, these actions help manufacturers and healthcare providers navigate a rapidly evolving clinical and regulatory environment while preserving procedural quality and institutional budgets.

Robust and transparent research methodology combining stakeholder interviews clinical registry analysis regulatory review and supply chain evaluation to ensure defensible insights

This research synthesizes primary and secondary evidence sources to ensure a comprehensive, reproducible basis for conclusions and recommendations. Primary inputs include structured interviews with cardiac surgeons, perfusionists, hospital procurement leaders, and device engineers to capture procedural preferences, device performance perceptions, and procurement considerations. These qualitative insights were supplemented by analysis of clinical registries, peer-reviewed clinical trial reports, and regulatory filings to triangulate device safety profiles, procedural outcomes, and post-market surveillance signals.

Secondary research comprised a systematic review of relevant clinical literature, technical whitepapers, and manufacturer product specifications to map device feature sets and technological trajectories. Supply chain and trade policy analysis integrated customs and tariff schedules, public trade notices, and manufacturing investment announcements to assess sourcing implications. Data synthesis involved cross-validation of clinical claims against registry outcomes and reconciliation of stakeholder perspectives with documented regulatory events, producing a balanced and defensible understanding of device dynamics and strategic implications.

Synthesis of clinical technological and operational imperatives that define future pathways for device adoption innovation and strategic partnership in CABG care

The coronary artery bypass graft device ecosystem is at an inflection point where clinical innovation, regulatory scrutiny, and supply chain strategy intersect. Surgical teams continue to refine procedural techniques while device developers respond with targeted innovations that enhance procedural control, reduce physiological insult, and improve operational efficiency. At the same time, external pressures such as tariff measures, reimbursement dynamics, and hospital procurement priorities compel manufacturers to be more deliberate in where and how they manufacture, price, and support their products.

Looking forward, stakeholders who prioritize clinical evidence generation, device interoperability, and supply chain resilience will be better positioned to influence adoption decisions and sustain long-term partnerships with health systems. Cross-sector collaboration among clinicians, manufacturers, and payers will be essential to align technological potential with patient-centered outcomes and institutional imperatives. Ultimately, the most successful organizations will be those that combine technical excellence with pragmatic commercial models and demonstrable real-world performance.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Increasing adoption of off-pump coronary artery bypass grafting devices to reduce patient trauma and recovery times
  • 5.2. Rapid technological advancements in robotic assisted coronary artery bypass grafting systems improving surgical precision
  • 5.3. Rising demand for bioengineered and tissue engineered grafts addressing limitations of traditional saphenous vein conduits
  • 5.4. Integration of advanced imaging and intraoperative flow measurement devices to enhance bypass graft patency monitoring
  • 5.5. Expansion of minimally invasive endoscopic and thoracoscopic approaches reducing hospital stays and complication rates for CABG
  • 5.6. Collaborations between medical device companies and research institutes to develop next generation synthetic graft materials with improved biocompatibility
  • 5.7. Growing emphasis on patient specific 3D printed surgical guides and patient anatomy modeling for preoperative planning in CABG procedures
  • 5.8. Adoption of hybrid coronary revascularization strategies combining percutaneous intervention with minimally invasive bypass to optimize outcomes in complex cases
  • 5.9. Increasing regulatory approvals and reimbursement policies favoring advanced CABG devices in emerging healthcare markets across Asia and Latin America
  • 5.10. Leveraging artificial intelligence and big data analytics to predict graft patency and personalize postoperative care in CABG patients

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Coronary Artery Bypass Graft Devices Market, by Product Type

  • 8.1. Anastomosis Devices
    • 8.1.1. Compression Anastomosis Rings
    • 8.1.2. Stapling Devices
  • 8.2. Cardiopulmonary Bypass Systems
    • 8.2.1. Portable Systems
    • 8.2.2. Standard Heart-Lung Machines
  • 8.3. Clamps & Occluders
    • 8.3.1. Aortic Clamps
    • 8.3.2. Vascular Occluders
  • 8.4. Stabilizers
    • 8.4.1. Mechanical Stabilizers
    • 8.4.2. Suction Stabilizers

9. Coronary Artery Bypass Graft Devices Market, by Graft Type

  • 9.1. Arterial Grafts
    • 9.1.1. Internal Mammary Artery
    • 9.1.2. Radial Artery
  • 9.2. Venous Grafts
    • 9.2.1. Saphenous Vein

10. Coronary Artery Bypass Graft Devices Market, by Procedure Type

  • 10.1. Off-Pump
  • 10.2. On-Pump

11. Coronary Artery Bypass Graft Devices Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Hospitals

12. Coronary Artery Bypass Graft Devices Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Coronary Artery Bypass Graft Devices Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Coronary Artery Bypass Graft Devices Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Medtronic plc
    • 15.3.2. Abbott Laboratories
    • 15.3.3. Johnson & Johnson
    • 15.3.4. Terumo Corporation
    • 15.3.5. B. Braun Melsungen AG
    • 15.3.6. Getinge AB
    • 15.3.7. LivaNova PLC
    • 15.3.8. CryoLife, Inc.
    • 15.3.9. Teleflex Incorporated
    • 15.3.10. AtriCure, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY GRAFT TYPE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY GRAFT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. CORONARY ARTERY BYPASS GRAFT DEVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ANASTOMOSIS DEVICES, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ANASTOMOSIS DEVICES, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ANASTOMOSIS DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ANASTOMOSIS DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ANASTOMOSIS DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ANASTOMOSIS DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ANASTOMOSIS DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ANASTOMOSIS DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY COMPRESSION ANASTOMOSIS RINGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY COMPRESSION ANASTOMOSIS RINGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY COMPRESSION ANASTOMOSIS RINGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY COMPRESSION ANASTOMOSIS RINGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY COMPRESSION ANASTOMOSIS RINGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY COMPRESSION ANASTOMOSIS RINGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY STAPLING DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY STAPLING DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY STAPLING DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY STAPLING DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY STAPLING DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY STAPLING DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PORTABLE SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PORTABLE SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PORTABLE SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PORTABLE SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PORTABLE SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PORTABLE SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY STANDARD HEART-LUNG MACHINES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY STANDARD HEART-LUNG MACHINES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY STANDARD HEART-LUNG MACHINES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY STANDARD HEART-LUNG MACHINES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY STANDARD HEART-LUNG MACHINES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY STANDARD HEART-LUNG MACHINES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CLAMPS & OCCLUDERS, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CLAMPS & OCCLUDERS, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CLAMPS & OCCLUDERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CLAMPS & OCCLUDERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CLAMPS & OCCLUDERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CLAMPS & OCCLUDERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CLAMPS & OCCLUDERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CLAMPS & OCCLUDERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY AORTIC CLAMPS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY AORTIC CLAMPS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY AORTIC CLAMPS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY AORTIC CLAMPS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY AORTIC CLAMPS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY AORTIC CLAMPS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY VASCULAR OCCLUDERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY VASCULAR OCCLUDERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY VASCULAR OCCLUDERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY VASCULAR OCCLUDERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY VASCULAR OCCLUDERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY VASCULAR OCCLUDERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY STABILIZERS, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY STABILIZERS, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY STABILIZERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY STABILIZERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY STABILIZERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY STABILIZERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY STABILIZERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY STABILIZERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY MECHANICAL STABILIZERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY MECHANICAL STABILIZERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY MECHANICAL STABILIZERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY MECHANICAL STABILIZERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY MECHANICAL STABILIZERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY MECHANICAL STABILIZERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY SUCTION STABILIZERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY SUCTION STABILIZERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY SUCTION STABILIZERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY SUCTION STABILIZERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY SUCTION STABILIZERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY SUCTION STABILIZERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY GRAFT TYPE, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY GRAFT TYPE, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ARTERIAL GRAFTS, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ARTERIAL GRAFTS, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ARTERIAL GRAFTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ARTERIAL GRAFTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ARTERIAL GRAFTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ARTERIAL GRAFTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ARTERIAL GRAFTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ARTERIAL GRAFTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY INTERNAL MAMMARY ARTERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY INTERNAL MAMMARY ARTERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY INTERNAL MAMMARY ARTERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY INTERNAL MAMMARY ARTERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY INTERNAL MAMMARY ARTERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY INTERNAL MAMMARY ARTERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY RADIAL ARTERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY RADIAL ARTERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY RADIAL ARTERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY RADIAL ARTERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY RADIAL ARTERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY RADIAL ARTERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY VENOUS GRAFTS, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY VENOUS GRAFTS, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY VENOUS GRAFTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY VENOUS GRAFTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY VENOUS GRAFTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY VENOUS GRAFTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY VENOUS GRAFTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY VENOUS GRAFTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY SAPHENOUS VEIN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY SAPHENOUS VEIN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY SAPHENOUS VEIN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY SAPHENOUS VEIN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY SAPHENOUS VEIN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY SAPHENOUS VEIN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY OFF-PUMP, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY OFF-PUMP, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY OFF-PUMP, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY OFF-PUMP, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY OFF-PUMP, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY OFF-PUMP, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ON-PUMP, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ON-PUMP, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ON-PUMP, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ON-PUMP, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ON-PUMP, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ON-PUMP, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 153. AMERICAS CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 154. AMERICAS CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 155. AMERICAS CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 156. AMERICAS CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 157. AMERICAS CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ANASTOMOSIS DEVICES, 2018-2024 (USD MILLION)
  • TABLE 158. AMERICAS CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ANASTOMOSIS DEVICES, 2025-2032 (USD MILLION)
  • TABLE 159. AMERICAS CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 160. AMERICAS CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 161. AMERICAS CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CLAMPS & OCCLUDERS, 2018-2024 (USD MILLION)
  • TABLE 162. AMERICAS CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CLAMPS & OCCLUDERS, 2025-2032 (USD MILLION)
  • TABLE 163. AMERICAS CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY STABILIZERS, 2018-2024 (USD MILLION)
  • TABLE 164. AMERICAS CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY STABILIZERS, 2025-2032 (USD MILLION)
  • TABLE 165. AMERICAS CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY GRAFT TYPE, 2018-2024 (USD MILLION)
  • TABLE 166. AMERICAS CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY GRAFT TYPE, 2025-2032 (USD MILLION)
  • TABLE 167. AMERICAS CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ARTERIAL GRAFTS, 2018-2024 (USD MILLION)
  • TABLE 168. AMERICAS CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ARTERIAL GRAFTS, 2025-2032 (USD MILLION)
  • TABLE 169. AMERICAS CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY VENOUS GRAFTS, 2018-2024 (USD MILLION)
  • TABLE 170. AMERICAS CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY VENOUS GRAFTS, 2025-2032 (USD MILLION)
  • TABLE 171. AMERICAS CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 172. AMERICAS CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 173. AMERICAS CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 174. AMERICAS CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 175. NORTH AMERICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 176. NORTH AMERICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 177. NORTH AMERICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 178. NORTH AMERICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 179. NORTH AMERICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ANASTOMOSIS DEVICES, 2018-2024 (USD MILLION)
  • TABLE 180. NORTH AMERICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ANASTOMOSIS DEVICES, 2025-2032 (USD MILLION)
  • TABLE 181. NORTH AMERICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 182. NORTH AMERICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 183. NORTH AMERICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CLAMPS & OCCLUDERS, 2018-2024 (USD MILLION)
  • TABLE 184. NORTH AMERICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CLAMPS & OCCLUDERS, 2025-2032 (USD MILLION)
  • TABLE 185. NORTH AMERICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY STABILIZERS, 2018-2024 (USD MILLION)
  • TABLE 186. NORTH AMERICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY STABILIZERS, 2025-2032 (USD MILLION)
  • TABLE 187. NORTH AMERICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY GRAFT TYPE, 2018-2024 (USD MILLION)
  • TABLE 188. NORTH AMERICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY GRAFT TYPE, 2025-2032 (USD MILLION)
  • TABLE 189. NORTH AMERICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ARTERIAL GRAFTS, 2018-2024 (USD MILLION)
  • TABLE 190. NORTH AMERICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ARTERIAL GRAFTS, 2025-2032 (USD MILLION)
  • TABLE 191. NORTH AMERICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY VENOUS GRAFTS, 2018-2024 (USD MILLION)
  • TABLE 192. NORTH AMERICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY VENOUS GRAFTS, 2025-2032 (USD MILLION)
  • TABLE 193. NORTH AMERICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 194. NORTH AMERICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 195. NORTH AMERICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 196. NORTH AMERICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 197. LATIN AMERICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 198. LATIN AMERICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 199. LATIN AMERICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 200. LATIN AMERICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 201. LATIN AMERICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ANASTOMOSIS DEVICES, 2018-2024 (USD MILLION)
  • TABLE 202. LATIN AMERICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ANASTOMOSIS DEVICES, 2025-2032 (USD MILLION)
  • TABLE 203. LATIN AMERICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 204. LATIN AMERICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 205. LATIN AMERICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CLAMPS & OCCLUDERS, 2018-2024 (USD MILLION)
  • TABLE 206. LATIN AMERICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CLAMPS & OCCLUDERS, 2025-2032 (USD MILLION)
  • TABLE 207. LATIN AMERICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY STABILIZERS, 2018-2024 (USD MILLION)
  • TABLE 208. LATIN AMERICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY STABILIZERS, 2025-2032 (USD MILLION)
  • TABLE 209. LATIN AMERICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY GRAFT TYPE, 2018-2024 (USD MILLION)
  • TABLE 210. LATIN AMERICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY GRAFT TYPE, 2025-2032 (USD MILLION)
  • TABLE 211. LATIN AMERICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ARTERIAL GRAFTS, 2018-2024 (USD MILLION)
  • TABLE 212. LATIN AMERICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ARTERIAL GRAFTS, 2025-2032 (USD MILLION)
  • TABLE 213. LATIN AMERICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY VENOUS GRAFTS, 2018-2024 (USD MILLION)
  • TABLE 214. LATIN AMERICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY VENOUS GRAFTS, 2025-2032 (USD MILLION)
  • TABLE 215. LATIN AMERICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 216. LATIN AMERICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 217. LATIN AMERICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 218. LATIN AMERICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 219. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 220. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 221. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 222. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 223. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ANASTOMOSIS DEVICES, 2018-2024 (USD MILLION)
  • TABLE 224. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ANASTOMOSIS DEVICES, 2025-2032 (USD MILLION)
  • TABLE 225. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 226. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 227. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CLAMPS & OCCLUDERS, 2018-2024 (USD MILLION)
  • TABLE 228. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CLAMPS & OCCLUDERS, 2025-2032 (USD MILLION)
  • TABLE 229. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY STABILIZERS, 2018-2024 (USD MILLION)
  • TABLE 230. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY STABILIZERS, 2025-2032 (USD MILLION)
  • TABLE 231. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY GRAFT TYPE, 2018-2024 (USD MILLION)
  • TABLE 232. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY GRAFT TYPE, 2025-2032 (USD MILLION)
  • TABLE 233. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ARTERIAL GRAFTS, 2018-2024 (USD MILLION)
  • TABLE 234. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ARTERIAL GRAFTS, 2025-2032 (USD MILLION)
  • TABLE 235. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY VENOUS GRAFTS, 2018-2024 (USD MILLION)
  • TABLE 236. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY VENOUS GRAFTS, 2025-2032 (USD MILLION)
  • TABLE 237. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 238. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 239. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 240. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 241. EUROPE CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 242. EUROPE CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 243. EUROPE CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 244. EUROPE CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 245. EUROPE CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ANASTOMOSIS DEVICES, 2018-2024 (USD MILLION)
  • TABLE 246. EUROPE CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ANASTOMOSIS DEVICES, 2025-2032 (USD MILLION)
  • TABLE 247. EUROPE CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 248. EUROPE CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 249. EUROPE CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CLAMPS & OCCLUDERS, 2018-2024 (USD MILLION)
  • TABLE 250. EUROPE CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CLAMPS & OCCLUDERS, 2025-2032 (USD MILLION)
  • TABLE 251. EUROPE CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY STABILIZERS, 2018-2024 (USD MILLION)
  • TABLE 252. EUROPE CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY STABILIZERS, 2025-2032 (USD MILLION)
  • TABLE 253. EUROPE CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY GRAFT TYPE, 2018-2024 (USD MILLION)
  • TABLE 254. EUROPE CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY GRAFT TYPE, 2025-2032 (USD MILLION)
  • TABLE 255. EUROPE CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ARTERIAL GRAFTS, 2018-2024 (USD MILLION)
  • TABLE 256. EUROPE CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ARTERIAL GRAFTS, 2025-2032 (USD MILLION)
  • TABLE 257. EUROPE CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY VENOUS GRAFTS, 2018-2024 (USD MILLION)
  • TABLE 258. EUROPE CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY VENOUS GRAFTS, 2025-2032 (USD MILLION)
  • TABLE 259. EUROPE CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 260. EUROPE CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 261. EUROPE CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 262. EUROPE CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 263. MIDDLE EAST CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 264. MIDDLE EAST CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 265. MIDDLE EAST CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 266. MIDDLE EAST CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 267. MIDDLE EAST CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ANASTOMOSIS DEVICES, 2018-2024 (USD MILLION)
  • TABLE 268. MIDDLE EAST CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ANASTOMOSIS DEVICES, 2025-2032 (USD MILLION)
  • TABLE 269. MIDDLE EAST CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 270. MIDDLE EAST CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 271. MIDDLE EAST CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CLAMPS & OCCLUDERS, 2018-2024 (USD MILLION)
  • TABLE 272. MIDDLE EAST CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CLAMPS & OCCLUDERS, 2025-2032 (USD MILLION)
  • TABLE 273. MIDD